ZHEJIANG HAISEN PHARMACEUTICAL CO., LTD.

Zhejiang Haisen Pharmaceutical Co., Ltd.

001367

CNE1000061L9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
39.18 ^CNY	+2.00%		+1.95%	-10.87%

May. 20	Zhejiang Haisen Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	CI
Apr. 24	Zhejiang Haisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Zhejiang Haisen Pharmaceutical Co., Ltd. has completed an IPO in the amount of CNY 756.16 million.

April 03, 2023 at 12:00 am EDT

Zhejiang Haisen Pharmaceutical Co., Ltd. has completed an IPO in the amount of CNY 756.16 million.

Security Name: A Shares
Security Type: Common Stock
Securities Offered: 3,400,000
PriceRange: CNY 44.48

Security Name: A Shares
Security Type: Common Stock
Securities Offered: 13,600,000
PriceRange: CNY 44.48

Latest news about Zhejiang Haisen Pharmaceutical Co., Ltd.

Zhejiang Haisen Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023	May. 20	CI
Zhejiang Haisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Zhejiang Haisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 22	CI
Certain A Shares of Zhejiang Haisen Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-APR-2024.	Apr. 09	CI
Zhejiang Haisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Zhejiang Haisen Pharmaceutical Co., Ltd. Announces Directorate Appointments	23-09-28	CI
Haisen Pharmaceutical to Invest 3 Billion Yuan on New Factory	23-09-19	MT
Cheng Yi Pharmaceutical Gains Nod to Market Osteoarthritis Drug Ingredient	23-09-19	MT
Zhejiang Haisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Zhejiang Haisen Pharmaceutical Co., Ltd. has completed an IPO in the amount of CNY 756.16 million.	23-04-03	CI
Zhejiang Haisen Pharmaceutical Co., Ltd. has filed an IPO.	23-02-20	CI

Chart Zhejiang Haisen Pharmaceutical Co., Ltd.

Duration

Period

Chart Zhejiang Haisen Pharmaceutical Co., Ltd.

More charts

Company Profile

Zhejiang Haisen Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical active pharmaceutical ingredient (APIs) and intermediates. The Company's main drugs include digestive system drugs, antipyretic and analgesic drugs, cardiovascular APIs, antidepressants drugs, antibacterial APIs, antiviral drugs, non-steroidal anti-inflammatory and other specialty APIs and preparations. The Company mainly conducts its businesses in domestic and overseas markets.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG HAISEN PHARMACEUTICAL CO., LTD.	-10.87%	368M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B